Neurodevelopmental Disorders: Genetic Studies and Therapeutic Strategies
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Genetics".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 2843
Special Issue Editors
Interests: mouse models of neurodevelopmental disorders; behavioral phenotyping; mouse behavior; autism spectrum disorders; Williams–Beuren syndrome
Special Issue Information
Dear Colleagues,
Neurodevelopmental disorders (NDDs) have been modeled in laboratory mice and rats through a variety of genetic and environmental approaches over the past few decades. Mouse models based on genetic mutations have been widely employed to explore the pathological mechanisms underlying NDDs and to identify novel therapeutic targets.
Our Special Issue will focus on such preclinical research, providing novel insight into the molecular pathways involved in NDDs and suggesting valid therapeutic approaches. We welcome studies involving basic research on rodent models of all NDDs, including Autism spectrum disorders, Schizophrenia, Down syndrome, and rare NDDs. Articles proposing novel pharmacological and non-pharmacological therapeutic approaches in pre-clinical models, as well as those investigating pathological pathways, are strongly encouraged. Findings describing novel genetic rodent models of NDDs will be included; pertinent non-genetic approaches will also be considered.
Dr. Susanna Pietropaolo
Dr. Bruno Bontempi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mouse models
- Autism Spectrum disorder
- transgenic rodents
- pharmacological treatments
- gene-environment interactions
- neurodevelopmental disorders
- rare diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Chronic Administration of BMS-204352 Exerts Limited Neurobehavioral Effects in a Mouse Model of Fragile X Syndrome
Authors: Susanna Pietropaolo
Affiliation: Univ. Bordeaux, CNRS, EPHE, INCIA, UMR 5287, F-33000 Bordeaux, France
Title: Database-Assisted Screening of Autism Spectrum Disorder Related Gene Set
Authors: Kereszturi Éva
Affiliation: Semmelweis University
Title: Gene therapy for Fragile X syndrome, challenges and promises
Authors: Milen Velinov
Affiliation: Rutgers Robert Wood Johnson Medical School